VIRIDIUN LLC Cumming, GA May 2014 to Feb 2015 CDL TRUCK DRIVERRESEARCH AL LOYS Columbus, OH Mar 2011 to May 2014 CDL TRUCK DRIVERFREEDOM RECYCLING Newark, OH Mar 2009 to Mar 2011 CDL TRUCK DRIVERD&G DOZER TANK TRUCK SERVICE LLC Bowie, TX Jun 2008 to Mar 2009 SALT WATER TRUCK DRIVER/DISPATCHER/TRAINERTSC SIEBER SERVICES Arp, TX Jan 2008 to Apr 2008 LABOR HANDSUNCOAST PIPELINE CO Purvis, MS Aug 2007 to Dec 2007 LABOR HAND/PAINTER
Education:
TRUCK DRIVING INSTITUTE Dallas, TX Apr 2008 to May 2008 D.O. in laws
Writing recently in NEJM, Harvard Universitys Daniel Carpenter suggested that Gottliebs libertarian ideas about drug regulation would politicize the drug approval process, give deep-pocketed pharmaceutical companies a dangerous edge in the approvals process, and erode the safety and effectiveness
Date: Apr 06, 2017
Category: Health
Source: Google
Obama's Pick to Lead FDA Nears Senate Confirmation
Daniel Carpenter, a social scientist at Harvard University in Cambridge, Massachusetts, says that Califf's nomination will likely not be the last that sparks debate over potential industry influence in government.
Date: Feb 23, 2016
Category: Health
Source: Google
Ezra Klein: 23andme challenges a creaky regulatory state
The legal question is pretty simple, said Daniel Carpenter, author of Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA. The definition of a device under the Federal Food, Drug and Cosmetics Act, Carpenter said, is anything intended for the use or diagnosis of
Date: Dec 06, 2013
Category: Health
Source: Google
Viewpoints: Berwick's Advice; Romney's Wager; Fighting AIDS
The New York Times: Free The FDA The unilateral decision last week by Kathleen Sebelius, the secretary of health and human services, to block the Plan B One-Step contraceptive pill from being sold to adolescents without a prescription is shocking in more ways than one (Daniel Carpenter, 12/13)
In the aftermath of Sebeliuss decision, some are calling for the Food and Drug Administration to become more independent. Daniel Carpenter a professor of government at Harvard wrote in the New York Times yesterday that Sebeliuss decision sets a radical precedent:
The company has used a number of "philosophical and political arguments to oppose the FDA's proposed withdrawal of the indication," explained Daniel Carpenter, PhD, of the Department of Government at Harvard, who was the lead author of an online Perspective published Monday in the New England Journa